Therapeutic drug monitoring for imatinib: Current status and Indian experience

Imatinib is the current gold standard for treatment of chronic myeloid leukemia (CML). Recent pharmacokinetic studies have shown considerable variability in trough concentrations of imatinib due to variations in its metabolism, poor compliance, or drug-drug interactions and highlighted its impact on...

Descripción completa

Detalles Bibliográficos
Autores principales: Arora, Brijesh, Gota, Vikram, Menon, Hari, Sengar, Manju, Nair, Reena, Patial, Pankaj, Banavali, S. D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3902632/
https://www.ncbi.nlm.nih.gov/pubmed/24516317
http://dx.doi.org/10.4103/0971-5851.123752

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3902632/
https://www.ncbi.nlm.nih.gov/pubmed/24516317
http://dx.doi.org/10.4103/0971-5851.123752

Ejemplares similares